AIDS Treatment News - 1992
- AIDS Treatment News - 1992
- Issue #142
- Tat Inhibitor Update
- Clinical Trials: Asking the Right Questions -- Interview with Lewis Sheiner, M. D.
- AIDS TREATMENT NEWS Selected Index
- Issue #143
- Community Research Group, San Diego: Interview with Gary R. Lewis, Ph.D.
- In Memoriam: Michael Wright
- Acyclovir: Maybe Good News -- but Press Confusion
- Issue #144
- Experimental Viral Tests for HIV Disease Progression
- AZT: European Study Stopped, Disease Progression Reduced
- Melanin: Negative Reports
- Disability Regulation Problems; Public Comment Deadline February 18
- FDA Tests Buyers' Club ddC
- Issue #145
- ddC: Buyers' Clubs Discontinue Sales After Potency Variations Found
- ddC Background
- Announcements
- Issue #146
- Hypericin, February 1992
- AIDS Research Budget Threatened
- Announcements
- Issue #147
- AIDS Origin Theory: Polio Vaccine?
- Treatment Activism Today
- San Francisco: Study of Septra (Bactrim) Desensitization
- Issue #148
- Passive Hyperimmune Therapy (Passive Immunotherapy): New Data Released, California Approval PossiblE
- Anti-Drug Politics Impede Medical Use of Marijuana
- Issue #149
- CMV: Laboratory Study of Etoposide
- Antivirals, Vaccines, Passive Immunotherapy: Talk by Marcus Conant, M. D.
- San Francisco: Health Care Workers' Respiratory Hazards Conference, May 1 & 2
- San Francisco Area Clinical Trials Directory
- FDA Antiviral Advisory Committee Meeting to Consider ddC, ddI, Markers
- Rifabutin Available to Prevent MAC
- CMV: Long-Awaited Trial of HPMPC
- Issue #150
- HIV/Endocrine Update
- ddC: AZT Combination Approval Recommended
- ddI: Good News, Questions Remain
- AZT: New Survival Data
- Issue #151
- Immune Restoration Conference: Interview with Martin Delaney of Project Inform
- Announcements
- Issue #152
- NAC: Is It Absorbed?
- Announcements
- Resources
- Gamma Globulin to Prevent Infections?
- International Travel with HIV
- In Memoriam: Scott Slutsky
- Issue #153
- Trial to Stop Mother-to-Baby Transmission Set to Begin
- Announcements:
- Tat Drug Development: Current Status by John S. James
- International Conference:
- Issue #154
- DDC Approved for AZT Combination
- Pain Control Access at Stake in Congressional Bill
- Mother-Infant Trial Suspended Due to Liability Issue; Year's Delay Expected
- Issue #155
- Books: Medical; History
- Intrernational Edition Contents:
- Combination Antivirals: ddC Plus AZT Approved
- Gamma Globulin: Inexpensive Treatment May Help Prevent Infections
- Hypericin: Antiviral from St. John's Wort
- International Conference: Advance Overview
- AIDS Action Council Hires Derek Hodel As Treatment Advocate; Expands Political Assistance
- 3-Drug Combination Trial: ddC+AZT+Interferon
- Issue #156
- International Conference: Major Themes
- Medical Marijuana: Overwhelming Support at San Francisco Hearing
- Neurology Funding Good News: Activists' NIH Study Pays Off
- International Conference: Antiretrovirals (Part I)
- Issue #157
- Clinical Trials and Observational Studies
- Upcoming Senate Vote on "Budget Wall"
- Issue #158
- Announcements
- Leads on New Drugs: Published-Only Abstracts from International AIDS Conference, Basic Science Track
- What Could the White House Do to Fight the Epidemic?
- Issue #159
- From the Editor
- "Parallel Track" d4T Access About to Begin
- d4T (Stavudine) Background
- AIDS TREATMENT NEWS Developing International Treatment Newsletter
- ICAAC Conference October 11-14, Anaheim, California
- Alpha-APA: New Anti-HIV Compound
- Yohimbine: Accidental Discovery As Fatigue Treatment?
- Issue #160
- ddI: FDA Approves Additional Indication
- Rifabutin: FDA Advisory Committee Recommends for MAC Prophylaxis
- International Conference and Clinical Practice: Interview with Kenneth Mayer, M. D.
- 566C80 (Atovaquone): FDA Advisory Committee Recommends Approval for Pneumocystis Treatment
- Issue #161
- Warning: Ultraviolet Light May Stimulate HIV
- HIV Treatment in Prison: Vacaville Update
- Itraconazole for Eosinophilic Folliculitis: Interview with Marcus Conant, M. D.
- Psychological Health and the Immune System
- Itraconazole Approved
- d4T Parallel-Track Program Begins
- TB Diagnosis: New Test Gives 48-Hour Result
- Issue #162
- Anger at Women's History Study Delay
- Kaposi's Sarcoma Trial Recruiting: TNP-470 (AGM-1470), New Kind of Treatment
- Issue #163
- Call to Activists: Focus Needed on Early Human Research
- Protecting Body Composition in HIV Infection: Interview with Nutritionist Cade Fields Newman
- Issue #164
- Biggest Research Snafu: New Antivirals Neglected
- Atovaquone (Mepron; 566C80) Approved for Pneumocystis; Drug Development, Activism Success
- Fetal Tissue Research Background
- Issue #165
- AIDS TREATMENT NEWS Selected Index
- Acyclovir Annual Price Cap for Some Patients, $2500; Registration Required
source: AIDS Treatment News
